Lexpos News

/Lexpos News

Chief Pharmaceutical Officer writes to sector about Pharmacy First

The Chief Pharmaceutical Officer (CPhO) for England, David Webb, has written to the community pharmacy sector about the Pharmacy First service in an end of year letter. Whilst thanking pharmacy colleagues for making a “valuable contribution” to the NHS this year, the CPhO notes that the agreement of the national Pharmacy First service marks a [...]

The post Chief Pharmaceutical Officer writes to sector about Pharmacy First appeared first on Community Pharmacy England.

By |December 18th, 2023|Lexpos News|Comments Off on Chief Pharmaceutical Officer writes to sector about Pharmacy First

2023 mandatory workforce survey closes on Sunday

Pharmacy owners have until Sunday (17th December 2023) to complete the 2023 workforce survey, which is a mandatory requirement for all pharmacy owners. The NHS Business Services Authority sent an email to pharmacy owners containing a link to the survey on 23rd October 2023; the survey can also be accessed via the following link: Access [...]

The post 2023 mandatory workforce survey closes on Sunday appeared first on Community Pharmacy England.

By |December 15th, 2023|Lexpos News|Comments Off on 2023 mandatory workforce survey closes on Sunday

DHSC permits use of antiviral medicines against influenza

The Department of Health and Social Care (DHSC) has via its Central Alerting System (CAS) published a letter on 14 December 2023 advising that due to increasing flu levels in the community, Prescribers working in primary care may now prescribe, and community pharmacists may now supply antiviral medicines (oseltamivir and zanamivir) for the prophylaxis and treatment [...]

The post DHSC permits use of antiviral medicines against influenza appeared first on Community Pharmacy England.

By |December 14th, 2023|Lexpos News|Comments Off on DHSC permits use of antiviral medicines against influenza

MHRA Class 3 Medicines Recall: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited)

Drug alert number: EL (23)A/44 Date issued: 14 December 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited) PL 50674/0011 SNOMED Code: N/A Batch Number Expiry Date Pack Size First Distributed BF22004504 Dec-2024 12 x 8 27th April [...]

The post MHRA Class 3 Medicines Recall: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited) appeared first on Community Pharmacy England.

By |December 14th, 2023|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Posaconazole Biocon 100mg Gastro-resistant Tablets (Biocon Pharma UK Limited)

December 2023 Price Concessions 1st Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (14/12/2023) announced the following initial list of price concessions for December 2023. Community Pharmacy England has received a large number of reports of products not available at their [...]

The post December 2023 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |December 14th, 2023|Lexpos News|Comments Off on December 2023 Price Concessions 1st Update